Nov 11 (Reuters) - Jazz Pharmaceuticals PLC JAZZ.O:
JAZZ PHARMACEUTICALS SHOWCASES NEW CLINICAL AND TRANSLATIONAL DATA FOR MODEYSO™ (DORDAVIPRONE) IN H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA AT SNO 2025
Source text: ID:nPn1t4sQja
Further company coverage: JAZZ.O
((reuters.briefs@thomsonreuters.com;))